ENTITY

ProKidney (PROK US)

Analysis

Health Care • United States

ProKidney Corp operates as a biotech company. The Company develops therapies that repairs and restores diseased kidneys using a patient's own cells and may prevent or delay dialysis or transplant. ProKidney serves customers worldwide.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00